GENOCEA BIOSCIENCES INC's ticker is GNCA and the CUSIP is 372427401. A total of 42 filers reported holding GENOCEA BIOSCIENCES INC in Q3 2021. The put-call ratio across all filers is 0.17 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $379,000 | -18.0% | 197,345 | 0.0% | 2.69% | +263.5% |
| Q2 2021 | $462,000 | -13.6% | 197,345 | 0.0% | 0.74% | +6.6% |
| Q1 2021 | $535,000 | +11.9% | 197,345 | 0.0% | 0.69% | +11.2% |
| Q4 2020 | $478,000 | +5.8% | 197,345 | 0.0% | 0.62% | -16.2% |
| Q3 2020 | $452,000 | -20.1% | 197,345 | -19.8% | 0.74% | +68.9% |
| Q2 2020 | $566,000 | +33.8% | 246,078 | 0.0% | 0.44% | +15.1% |
| Q1 2020 | $423,000 | -16.9% | 246,078 | 0.0% | 0.38% | +3.5% |
| Q4 2019 | $509,000 | -28.7% | 246,078 | 0.0% | 0.37% | -8.9% |
| Q3 2019 | $714,000 | -26.0% | 246,078 | 0.0% | 0.41% | -46.4% |
| Q2 2019 | $965,000 | – | 246,078 | – | 0.76% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 375,000 | $878,000 | 2.94% |
| COMMODORE CAPITAL LP | 2,929,447 | $6,855,000 | 2.39% |
| Polaris Venture Management Co. V, L.L.C. | 197,345 | $462,000 | 0.74% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,972,056 | $4,615,000 | 0.54% |
| BVF INC/IL | 4,012,404 | $9,389,000 | 0.35% |
| NEA Management Company, LLC | 10,376,936 | $24,282,000 | 0.32% |
| Avoro Capital Advisors LLC | 5,084,184 | $11,897,000 | 0.21% |
| Diametric Capital, LP | 69,977 | $164,000 | 0.12% |
| Boxer Capital, LLC | 1,134,453 | $2,655,000 | 0.09% |
| Ikarian Capital, LLC | 200,000 | $468,000 | 0.04% |